Drug Shortage Report for MAR-LACOSAMIDE

Last updated on 2023-07-13 History
Report ID 137165
Drug Identification Number 02487829
Brand name MAR-LACOSAMIDE
Common or Proper name LACOSAMIDE
Company Name MARCAN PHARMACEUTICALS INC
Market Status DORMANT
Active Ingredient(s) LACOSAMIDE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 60 Tablets
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-04-09
Actual start date 2021-04-09
Estimated end date 2022-08-31
Actual end date 2022-07-06
Shortage status Resolved
Updated date 2023-07-13
Company comments Business reasons
Health Canada comments
Tier 3 Status No
Contact Address 2 GURDWARA RD., SUITE 112
OTTAWA, ONTARIO
CANADA K2E 1A2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-07-13 French Compare
v6 2023-07-13 English Compare
v5 2021-08-31 French Compare
v4 2021-08-31 English Compare
v3 2021-04-10 English Compare
v2 2021-04-08 French Compare
v1 2021-04-08 English Compare

Showing 1 to 7 of 7